Published 10 days ago • loading... • Updated 10 days ago

Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses

The CEO spoke with BioPharma Dive about convincing investors to buy into the first gene editing IPO in more than two years.

1 Articles

biopharmadive.com

Center

Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses

The CEO spoke with BioPharma Dive about convincing investors to buy into the first gene editing IPO in more than two years.

10 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated10 days agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharmadive.com broke the news 10 days ago on Monday, August 10, 2026.

Sources are mostly out of (0)

Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses

1 Articles

1 Articles

Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

OpenAI 'will be a public company in 2027' or sooner, CFO Friar tells employees

China’s backflipping robot maker Unitree pops 542% in Shanghai debut

OpenAI’s Second-Quarter Sales Show Tepid Growth Compared With Anthropic

Indian Fintech Navi to Raise $100 Million Ahead of Planned IPO

Unitree's New Robot Can Sprint Faster Than Usain Bolt, Though the Way It Moves May Give You Nightmares About Demons

Anthropic Pre-IPO Credit Facility Set to Climb Past $10 Billion

Similar News Topics

Similar News Topics

More stories like this

OpenAI 'will be a public company in 2027' or sooner, CFO Friar tells employees

China’s backflipping robot maker Unitree pops 542% in Shanghai debut

OpenAI’s Second-Quarter Sales Show Tepid Growth Compared With Anthropic

Indian Fintech Navi to Raise $100 Million Ahead of Planned IPO

Unitree's New Robot Can Sprint Faster Than Usain Bolt, Though the Way It Moves May Give You Nightmares About Demons

Anthropic Pre-IPO Credit Facility Set to Climb Past $10 Billion

Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses

1 Articles

1 Articles

Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

OpenAI 'will be a public company in 2027' or sooner, CFO Friar tells employees

China’s backflipping robot maker Unitree pops 542% in Shanghai debut

OpenAI’s Second-Quarter Sales Show Tepid Growth Compared With Anthropic

Indian Fintech Navi to Raise $100 Million Ahead of Planned IPO

Unitree's New Robot Can Sprint Faster Than Usain Bolt, Though the Way It Moves May Give You Nightmares About Demons

Anthropic Pre-IPO Credit Facility Set to Climb Past $10 Billion

Similar News Topics

Similar News Topics

More stories like this

OpenAI 'will be a public company in 2027' or sooner, CFO Friar tells employees

China’s backflipping robot maker Unitree pops 542% in Shanghai debut

OpenAI’s Second-Quarter Sales Show Tepid Growth Compared With Anthropic

Indian Fintech Navi to Raise $100 Million Ahead of Planned IPO

Unitree's New Robot Can Sprint Faster Than Usain Bolt, Though the Way It Moves May Give You Nightmares About Demons

Anthropic Pre-IPO Credit Facility Set to Climb Past $10 Billion

Bias Distribution

Factuality